Robson RA - Search Results

1

Robson RA. Robson RA. Int J Antimicrob Agents. 1992 Dec;2(1):3-10. doi: 10.1016/0924-8579(92)90020-r. Int J Antimicrob Agents. 1992. PMID: 18611512

2

The effects of quinolones on xanthine pharmacokinetics.

Robson RA. Robson RA. Am J Med. 1992 Apr 6;92(4A):22S-25S. doi: 10.1016/0002-9343(92)90303-s. Am J Med. 1992. PMID: 1580270 Review.

3

Investigating clinically adequate concentrations of oseltamivir carboxylate in end-stage renal disease patients undergoing hemodialysis using a population pharmacokinetic approach.

Kamal MA, Lien KY, Robson R, Subramoney V, Clinch B, Rayner CR, Gibiansky L. Kamal MA, et al. Antimicrob Agents Chemother. 2015 Nov;59(11):6774-81. doi: 10.1128/AAC.01024-15. Epub 2015 Aug 17. Antimicrob Agents Chemother. 2015. PMID: 26282419 Free PMC article.

4

Effects of Oritavancin on Coagulation Tests in the Clinical Laboratory.

Belley A, Robson R, Francis JL, Adcock DM, Tiefenbacher S, Rubino CM, Moeck G, Sylvester D, Dudley MN, Loutit J. Belley A, et al. Antimicrob Agents Chemother. 2017 Jan 24;61(2):e01968-16. doi: 10.1128/AAC.01968-16. Print 2017 Feb. Antimicrob Agents Chemother. 2017. PMID: 27956417 Free PMC article. Clinical Trial.

5

Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender.

Robson R, White H, Aylward P, Frampton C. Robson R, et al. Clin Pharmacol Ther. 2002 Jun;71(6):433-9. doi: 10.1067/mcp.2002.124522. Clin Pharmacol Ther. 2002. PMID: 12087346 Clinical Trial.

6

The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis.

Robson R, Buttimore A, Lynn K, Brewster M, Ward P. Robson R, et al. Nephrol Dial Transplant. 2006 Sep;21(9):2556-62. doi: 10.1093/ndt/gfl267. Epub 2006 Jun 24. Nephrol Dial Transplant. 2006. PMID: 16799169 Clinical Trial.

7

Effects of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Inclisiran: An Analysis of the ORION-7 and ORION-1 Studies.

Wright RS, Collins MG, Stoekenbroek RM, Robson R, Wijngaard PLJ, Landmesser U, Leiter LA, Kastelein JJP, Ray KK, Kallend D. Wright RS, et al. Mayo Clin Proc. 2020 Jan;95(1):77-89. doi: 10.1016/j.mayocp.2019.08.021. Epub 2019 Oct 17. Mayo Clin Proc. 2020. PMID: 31630870 Clinical Trial.

8

The use of bivalirudin in patients with renal impairment.

Robson R. Robson R. J Invasive Cardiol. 2000 Dec;12 Suppl F:33F-6. J Invasive Cardiol. 2000. PMID: 11156732 Review.

9

Lack of a clinically important effect of moderate hepatic insufficiency and severe renal insufficiency on raltegravir pharmacokinetics.

Iwamoto M, Hanley WD, Petry AS, Friedman EJ, Kost JT, Breidinger SA, Lasseter KC, Robson R, Lunde NM, Wenning LA, Stone JA, Wagner JA. Iwamoto M, et al. Antimicrob Agents Chemother. 2009 May;53(5):1747-52. doi: 10.1128/AAC.01194-08. Epub 2009 Feb 17. Antimicrob Agents Chemother. 2009. PMID: 19223645 Free PMC article. Clinical Trial.

10

Pharmacokinetics and Bioavailability of a Fixed-Dose Combination of Ibuprofen and Paracetamol after Intravenous and Oral Administration.

Atkinson HC, Stanescu I, Frampton C, Salem II, Beasley CP, Robson R. Atkinson HC, et al. Clin Drug Investig. 2015 Oct;35(10):625-32. doi: 10.1007/s40261-015-0320-8. Clin Drug Investig. 2015. PMID: 26334726 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters